3.9 The government agrees with the Committee’s recommendation. Target Implementation date: January 2026 3.10 DHSC and NHSE wish to note the importance of also reporting on the delivery of physical capital assets. There are several capital elements to planned care: an electives programme and a cancer and diagnostics programme. 3.11 Currently the National Diagnostic Board and the groups feeding into it play an important assurance role in the delivery of diagnostic capital projects and report on delivery milestones as well as their impact on performance targets and alignment with policy objectives. 3.12 The monthly Elective Capital Programme Board has an important assurance function in the oversight of elective capital projects. This receives and scrutinises monthly reports on scheme completions, planned vs actual additional activity enabled from completed schemes and receipt of scheme post project evaluations. 3.13 Additionally, the monthly Elective Hubs Oversight Group receives performance reports for all surgical hubs, including on capped theatre utilisation (a measure of theatre productivity). It also receives reports from the national GIRFT hubs accreditation programme. 3.14 A National Institute for Health and Care Research (NIHR) Policy Research Programme evaluation of 2022-2025 Targeted Investment Fund schemes that are non-hubs will start in January 2026 and report in 2028. 3.15 From January 2026, the Diagnostic and Elective capital boards will merge to form a single Planned Care Capital Assurance Board, which will also monitor the delivery of capital projects which support cancer. This will consolidate existing work done within programmes to monitor outcomes and benefits and to report on the achievement of policy aims.